Nutex Health Inc.
NUTX | NASDAQ
$208.90
+$7.42 (+3.68%)
Sep 22, 2026, 2:18 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 875.26M | 479.95M | 247.65M | 219.29M | 331.53M | 274.03M |
Cost of Revenue | 430.98M | 283.69M | 212.87M | 203.87M | 152.25M | 116.42M |
Gross Profit | 444.28M | 196.26M | 34.77M | 15.42M | 179.28M | 157.61M |
Operating Income | 275.63M | 130.62M | -31.77M | -406.6M | 170.26M | 153.17M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 244.78M | 109.75M | -48.49M | -419.65M | 169.49M | 145.74M |
Net Income | 70.79M | 52.18M | -45.79M | -424.78M | 132.59M | 105.97M |
Selling & General & Admin | 168.66M | 58.56M | 36.07M | 20M | 5.46M | 4.43M |
Research & Development | n/a | n/a | n/a | n/a | 285.88K | n/a |
Other Expenses | n/a | 7.08M | 30.48M | 402.02M | 3.27M | n/a |
Operating Expenses | 168.66M | 65.64M | 66.55M | 422.02M | 9.02M | 4.43M |
Interest Expense | 22.23M | 19.93M | 16.32M | 12.49M | 6.2M | 6.43M |
Selling & Marketing Expenses | n/a | n/a | 2.84M | n/a | n/a | n/a |
Cost & Expenses | 599.63M | 349.33M | 279.42M | 625.89M | 161.27M | 120.86M |
Income Tax Expense | 64.42M | 14.48M | -5.07M | 13.09M | 965.73K | 181.34K |
Shares Outstanding (Basic) | 6.36M | 5.1M | 4.41M | 4.23M | 4.02M | 4.29M |
Shares Outstanding (Diluted) | 6.76M | 5.1M | 4.41M | 4.23M | 3.95M | 4.29M |
EPS (Basic) | 11.13 | 10.23 | -10.39 | -100.50 | 33.55 | 24.69 |
EPS (Diluted) | 10.48 | 9.71 | -10.39 | -100.36 | 33.55 | 24.69 |
EBITDA | 287.54M | 148.65M | -14.58M | -394.03M | 183.45M | 158.07M |
EBIT | 267.01M | 129.68M | -32.17M | -407.16M | 175.69M | 152.17M |
Depreciation & Amortization | 20.53M | 18.97M | 17.59M | 13.13M | 7.76M | 5.9M |
Add to Watchlist
Select watchlists to add or remove NUTX